Shots:

• The companies allied to support Takeda’s research stage gene therapy discovery programs across its core therapeutic areas i.e. oncology- rare diseases- neuroscience and gastroenterology
• The collaboration leverages s Evotec’s gene therapy capabilities along with its drug discovery platform to support Takeda’s programs
• The partnership will facilitate Takeda’s delivery of transformative therapies for patients- especially with rare diseases

Click here to­ read full press release/ article 

 Ref: Evotec | Image:Takeda